EuMelaReg gGmbH
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC (NCT05741073) | EuMelaReg gGmbH | 2023-06-30 |
| BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients (NCT03944356) | EuMelaReg gGmbH | 2019-07-01 |
Track EuMelaReg gGmbH automatically
Every clearance here is in the API, with alerts when new ones post.